VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
UHT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
UHTUniversal Health Realty Income Trust
$38.40$533M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksUHTFinancials

Universal Health Realty Income Trust (UHT) Income Statement

30Y historyFree accessUpdated daily

Revenue growth has stalled at 0.5% in 2026Q2, while the reported NOI margin plummeted to 8.7% from a historical average above 94%, indicating a severe and potentially structural shift in property-level profitability.

Income StatementBalance SheetCash FlowRatios

UHT Income Statement

Annual statement

UHT Income Statement

Universal Health Realty Income Trust (UHT) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue148.79M99.19M99.01M95.58M90.63M84.19M78.01M77.16M76.21M72.35M67.08M63.95M59.79M54.28M53.95M29.49M28.88M31.91M29.18M27.96M31.71M32.59M31.01M26.31M27.17M26.31M26.05M23.86M23.23M23.1M21.92M
Revenue Growth %50.97%0.18%3.6%5.46%7.64%7.92%1.1%1.25%5.34%7.85%4.9%6.96%10.14%0.61%82.92%2.13%-9.51%9.35%4.38%-11.84%-2.69%5.08%17.89%-3.17%3.25%0.99%9.17%2.72%0.58%5.37%7.38%
Property Operating Expenses35.56M5.59M5.48M5.32M5.1M4.41M4.14M3.97M3.81M3.58M3.26M2.81M2.54M2.37M2.12M2.01M1.85M00000000000000
Net Operating Income (NOI)113.22M93.59M93.53M90.25M85.53M79.78M73.87M73.19M72.4M68.77M63.82M61.14M57.24M51.91M51.83M27.49M27.03M31.91M29.18M27.96M31.71M32.59M31.01M26.31M27.17M26.31M26.05M23.86M23.23M23.1M21.92M
NOI Margin %76.1%94.36%94.46%94.43%94.38%94.77%94.69%94.85%95.01%95.06%95.14%95.61%95.74%95.64%96.07%93.19%93.59%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Operating Expenses58.98M58.83M56.73M58.9M54.86M50.92M47.87M47.44M45.7M44.73M41.7M40.5M38.19M33.37M35.47M18.76M11.72M13.98M17.19M11.12M13.01M13.25M10.91M7.37M8.06M7.7M7.35M8.44M6.94M6.63M5.83M
G&A Expenses2.81M000004.14M3.97M3.81M3.58M3.26M2.81M2.54M2.37M2.12M2.53M1.85M1.61M1.57M1.43M00000000000
EBITDA83.25M63.62M64.22M59.08M57.22M56.34M51.59M51.62M51.68M49.15M45.12M42.84M40.02M37.39M36.58M16.03M21.59M24.33M17.9M22.05M24.27M24.96M25.41M23.47M23.53M23.02M23.16M19.28M20.17M20.24M19.73M
EBITDA Margin %55.95%64.14%64.86%61.82%63.14%66.92%66.13%66.9%67.81%67.94%67.26%66.98%66.94%68.88%67.8%54.36%74.75%76.24%61.32%78.87%76.51%76.58%81.95%89.23%86.62%87.48%88.9%80.78%86.81%87.62%90%
Depreciation & Amortization29M28.86M27.42M27.73M26.56M27.48M25.58M25.87M24.98M25.12M23.01M22.2M20.98M18.84M20.22M7.31M6.29M6.4M5.9M5.21M5.56M5.62M5.31M4.54M4.43M4.4M4.46M3.86M3.88M3.77M3.64M
D&A / Revenue %19.49%29.09%27.69%29.02%29.3%32.64%32.79%33.53%32.77%34.72%34.3%34.71%35.08%34.71%37.47%24.77%21.77%20.05%20.23%18.63%17.53%17.25%17.13%17.24%16.31%16.73%17.12%16.16%16.7%16.34%16.59%
Operating Income54.25M34.76M36.8M31.35M30.67M28.86M26M25.75M26.7M24.04M22.11M20.64M19.05M18.55M16.36M8.73M15.3M17.93M11.99M16.84M18.7M19.34M20.1M18.94M19.1M18.62M18.7M15.42M16.29M16.46M16.09M
Operating Margin %36.46%35.05%37.16%32.8%33.84%34.29%33.33%33.37%35.04%33.22%32.97%32.27%31.86%34.17%30.32%29.59%52.98%56.19%41.09%60.24%58.98%59.33%64.82%71.99%70.31%70.76%71.78%64.62%70.11%71.28%73.41%
Interest Expense4M21.87M23.83M22.03M10.76M8.81M8.26M10.53M9.67M10.06M9.36M8.22M8.38M7.47M7.77M2.4M1.94M2.45M2.39M1.75M2.28M3.3M3.36M2.5M2.4M3.9M6.11M03.49M02.56M
Interest Coverage-1.77x1.81x1.70x2.96x13.39x3.35x2.80x3.50x5.53x2.84x3.88x7.15x2.76x3.51x31.72x9.41x7.33x6.93x9.63x8.19x5.86x9.24x10.54x14.98x6.75x4.26x-4.67x-6.70x
Non-Operating Income18.04M-3.96M-6.27M-6.08M-1.19M-89.11M-1.71M-3.75M-7.16M-31.64M-4.46M-11.28M-40.88M-2.1M-10.88M-67.47M-2.95M0-4.58M000-10.91M-7.37M-16.91M-7.7M-7.35M00-12.94M-1.1M
Pretax Income19.27M17.61M19.23M15.4M21.1M109.17M19.45M18.96M24.2M45.62M17.21M23.69M51.55M13.17M19.48M73.79M16.31M18.58M11.65M16.84M18.7M19.34M20.1M18.94M19.1M18.62M18.7M15.42M16.29M16.46M16.09M
Pretax Margin %12.95%17.75%19.43%16.11%23.28%129.67%24.93%24.58%31.75%63.05%25.66%37.05%86.23%24.26%36.1%250.2%56.48%58.21%39.93%60.24%58.98%59.33%64.82%71.99%70.31%70.76%71.78%64.62%70.11%71.28%73.41%
Income Tax0000000000000000000-2.82M-15.72M-5.79M-1.32M-4.2M-1.53M1.26M3.44M1.45M1.99M2.46M1.94M
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%-16.74%-84.06%-29.97%-6.58%-22.17%-8%6.77%18.38%9.4%12.22%14.97%12.03%
Net Income19.27M17.61M19.23M15.4M21.1M109.17M19.45M18.96M24.2M45.62M17.21M23.69M51.55M13.17M19.48M73.79M16.31M18.58M11.65M22.19M34.7M25.42M23.67M24.43M21.62M18.35M16.26M13.97M14.34M14M14.16M
Net Margin %12.95%17.75%19.43%16.11%23.28%129.67%24.93%24.58%31.75%63.05%25.66%37.05%86.23%24.26%36.1%250.2%56.48%58.21%39.93%79.37%109.41%78.01%76.33%92.85%79.59%69.73%62.39%58.55%61.71%60.61%64.58%
Net Income Growth %7.47%-8.45%24.9%-27.02%-80.67%461.35%2.55%-21.62%-46.96%165%-27.34%-54.04%291.46%-32.39%-73.61%352.45%-12.2%59.41%-47.49%-36.04%36.48%7.4%-3.09%12.96%17.84%12.88%16.35%-2.55%2.41%-1.12%4.23%
Funds From Operations (FFO)48.27M46.47M46.66M43.13M47.66M136.64M45.03M44.83M49.17M70.73M40.22M45.89M72.53M32.01M39.69M81.1M22.6M24.98M17.56M27.4M40.26M31.05M28.98M28.96M26.05M22.75M20.72M17.83M18.22M17.77M17.79M
FFO Margin %32.44%46.85%47.12%45.13%52.59%162.3%57.72%58.1%64.52%97.77%59.96%71.76%121.31%58.98%73.57%274.97%78.25%78.26%60.16%98%126.94%95.26%93.45%110.09%95.9%86.46%79.52%74.71%78.4%76.95%81.17%
FFO Growth %23.78%-0.4%8.17%-9.5%-65.12%203.46%0.43%-8.82%-30.48%75.86%-12.35%-36.73%126.56%-19.35%-51.06%258.91%-9.53%42.25%-35.92%-31.94%29.67%7.12%0.08%11.16%14.52%9.81%16.2%-2.12%2.48%-0.11%4.88%
FFO per Share3.483.353.373.123.459.923.273.263.585.192.993.455.612.523.136.411.842.101.482.313.392.622.452.462.222.162.301.992.031.981.99
FFO Payout Ratio %85.71%88.29%86.58%92.19%82.2%28.2%84.33%83.44%74.9%50.97%87.36%74.29%45.11%99.18%78.59%37.86%132.17%113.74%158%99.26%66.15%82.42%81.04%79.28%86.13%90.47%79.78%90.95%86.28%85.87%85.28%
EPS (Diluted)1.391.271.391.111.537.921.411.381.763.351.281.783.991.041.545.831.331.560.981.872.922.152.002.071.841.741.811.561.601.561.58
EPS Growth %8.53%-8.63%25.23%-27.45%-80.68%461.7%2.17%-21.59%-47.46%161.72%-28.09%-55.39%283.65%-32.47%-73.58%338.35%-14.74%59.18%-47.59%-35.96%35.81%7.5%-3.38%12.5%5.75%-3.87%16.03%-2.5%2.56%-1.27%3.95%
EPS (Basic)-1.271.391.121.537.941.421.381.763.351.281.783.991.041.545.841.331.560.981.872.942.162.022.091.851.751.811.561.601.561.58
Diluted Shares Outstanding13.88M13.86M13.84M13.81M13.79M13.78M13.77M13.75M13.72M13.63M13.47M13.3M12.93M12.7M12.67M12.65M12.26M11.9M11.88M11.88M11.87M11.84M11.81M11.78M11.75M10.54M9M8.98M8.97M8.97M8.96M

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Severe NOI Margin Volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Revenue Growth Stalls Amidst NOI Collapse

UHT's revenue growth has decelerated to just 0.5% in 2026Q2, while the reported NOI margin plummeted to 8.7%, a stark contrast to the consistent 94% margins seen in prior quarters, suggesting a significant operational or accounting shift.

The near-flat revenue growth indicates limited organic expansion or acquisition activity in recent periods. The dramatic collapse in the reported NOI margin from a stable ~94% to 8.7% in the latest quarter is the most critical trend, warranting immediate investigation into whether this reflects a change in accounting treatment, a large non-recurring expense, or a fundamental deterioration in property-level economics.

Property-Level Profitability Under Severe Pressure

Based on the reported figures, UHT's NOI margin collapsed to 8.7% in 2026Q2 from a historical average above 94%, indicating that operating expenses consumed nearly all revenue, a development that severely undermines the REIT's core earnings power.

The historical 94% NOI margin is atypically high for a healthcare REIT and may reflect a specific reimbursement or accounting structure. The sudden shift to an 8.7% margin suggests either a massive, non-recurring operating expense hit or a fundamental change in how expenses are reported against revenue. This volatility makes property-level profitability highly unpredictable and obscures the true cash flow generation of the portfolio.

FFO Growth Masks Underlying Earnings Deterioration

According to recent SEC filings, UHT's FFO per share grew 12.6% year-over-year in 2026Q2, yet this growth appears disconnected from the severe margin compression, raising questions about the quality and sustainability of the reported FFO figure.

The divergence between robust FFO growth and collapsing NOI margins is a major red flag. It suggests that the FFO calculation may be excluding significant cash costs or that non-cash items are distorting the GAAP net income figure used in the reconciliation. Investors should scrutinize the FFO add-backs, particularly regarding depreciation and any one-time adjustments, to assess the true recurring cash flow available for dividends.

GAAP Net Income Distorted by Depreciation Chasm

As reported in financial statements, UHT's GAAP net income of $5.9M in 2026Q2 is less than half of the $12.9M FFO, highlighting the massive depreciation charge that makes net income an unreliable metric for assessing this REIT's operational performance.

The persistent and large gap between FFO and net income is characteristic of capital-intensive real estate, but the scale here is pronounced. This depreciation charge, while non-cash, represents the accounting allocation of the portfolio's cost over time and obscures the near-term cash earnings. The analysis must focus on FFO and NOI to understand the business, as net income provides little insight into distributable cash flow.

Questionable Consistency of Historical Margin Profile

The most significant analytical challenge is the historical 94% NOI margin, which appears unusually high and stable for a healthcare facility REIT, suggesting potential non-standard accounting or reimbursement structures that may not reflect true economic cash flow.

A 94% NOI margin implies operating expenses are only 6% of revenue, which is atypical for properties requiring utilities, maintenance, insurance, and property taxes. This could indicate that a substantial portion of operating costs are being reimbursed by tenants and netted against revenue, or that certain expenses are capitalized rather than expensed. The sudden break in this pattern in 2026Q2 demands a review of the company's accounting policies and lease structures to understand if the historical margin was a true reflection of cash economics.

UHT — Frequently Asked Questions

Quick answers to the most common questions about buying UHT stock.

What was Universal Health Realty Income Trust's (UHT) revenue in 2025?

For fiscal year 2025, Universal Health Realty Income Trust (UHT) reported total revenue of $99.2M. This represents a 352.4% increase compared to $21.9M in 1996.

Is Universal Health Realty Income Trust (UHT) profitable?

Universal Health Realty Income Trust (UHT) is profitable, generating $17.6M in net income for the fiscal year ending 2025 with a net profit margin of 17.8%.

What is Universal Health Realty Income Trust's operating profit margin?

Universal Health Realty Income Trust (UHT) reported an operating income of $34.8M, resulting in an operating profit margin of 35.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Universal Health Realty Income Trust's gross profit and gross margin?

Universal Health Realty Income Trust (UHT) generated $93.6M in gross profit for the year, representing a gross profit margin of 94.4%. This demonstrates the company's core pricing power and production efficiency.